23andMe cuts 40% of its workforce, discontinues all therapy programs

(Reuters) -Genetic testing firm 23andMe said on Monday it is reducing about 40%, or 200 employees, from its workforce and discontinuing further development of all its therapies as part of a restructuring program.

"We are taking these difficult but necessary actions as we restructure 23andMe and focus on the long-term success of our core consumer business and research partnerships," said CEO Anne Wojcicki.

The company said it is evaluating strategic alternatives, including licensing agreements and asset sales, for its therapies in development.

Wojcicki, who has been trying to take the company private since April, is facing a tough challenge after independent directors of 23andMe resigned in September, after not receiving a satisfactory take-private offer from the CEO.



In July, the CEO and co-founder proposed to acquire all outstanding shares of the firm not already owned by her or her affiliates for 40 cents each.

After Monday's restructuring plan, the company expects annualized cost savings of more than $35 million.

Source: Investing.com

Последние публикации
US East Coast, Gulf Coast ports employer says no significant progress on key contract issue
13.11.2024 - 21:00
Disney, Applied Materials, Brookfield set to report Thursday
13.11.2024 - 21:00
PPI, jobless claims, and oil data in focus for Thursday's economic events
13.11.2024 - 21:00
Amazon, Chevron lead Wednesday's market cap stock movers
13.11.2024 - 21:00
Nelson Peltz says new Disney chairman Gorman will find a 'respectable CEO'
13.11.2024 - 21:00
Boeing starts issuing layoff notices as planemaker trims 10% of workforce
13.11.2024 - 21:00
Tesla recalls 2,400 Cybertrucks, 6th callback for the pickups this year
13.11.2024 - 20:00
US stocks rise after in-line inflation data firm up December rate-cut bets
13.11.2024 - 20:00
Amazon, IKEA join other ocean cargo shippers to boost demand for new green fuels
13.11.2024 - 20:00
Beirut bombing victims' $1.68 billion Iran judgment overturned by US appeals court
13.11.2024 - 19:00
Baltimore wins $266 million in opioid case against distributors
13.11.2024 - 19:00
Pentagon buys two new types of drones under Replicator initiative
13.11.2024 - 19:00
Germany stocks lower at close of trade; DAX down 0.30%
13.11.2024 - 19:00
Belgium stocks higher at close of trade; BEL 20 up 0.18%
13.11.2024 - 19:00
Portugal stocks lower at close of trade; PSI down 0.60%
13.11.2024 - 19:00

© Analytic DC. All Rights Reserved.

new
Анализ рынка Как повлият завтра отчет NFP на курс доллара США?